Serum beta-2-microglobulin in multiple myeloma: Relation to presenting features and clinical status
- 1 January 1982
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 18 (1) , 59-66
- https://doi.org/10.1016/0277-5379(82)90025-6
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Suppression of polyclonal immunoglobulins in multiple myeloma: Relationship to the staging and other manifestations at diagnosisClinical Immunology and Immunopathology, 1980
- Turnover in humans of β2‐microglobulin: the constant chain of HLA‐antigensEuropean Journal of Clinical Investigation, 1980
- REAPPRAISAL OF PLATEAU PHASE IN MYELOMAThe Lancet, 1980
- β2-MICROGLOBULIN, A TUMOUR MARKER OF LYMPHOPROLIFERATIVE DISORDERSThe Lancet, 1978
- β2-Microglobulin levels in cancerous and other disease statesClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- β2-Microglobulin: occurrence in fetal life and malignancyClinica Chimica Acta; International Journal of Clinical Chemistry, 1974
- Interpretation of Serum Calcium in Patients with Abnormal Serum ProteinsBMJ, 1973
- Serum β2-microglobulin in various disordersClinica Chimica Acta; International Journal of Clinical Chemistry, 1973
- The Serum Levels and Urinary Excretion of β2-Microglobulin in Apparently Healthy SubjectsScandinavian Journal of Clinical and Laboratory Investigation, 1972
- Microglobulinaemia in Renal FailureNature, 1968